Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Apnimed, Inc. before investing.

In this article, we go over a few key elements for understanding Apnimed, Inc.’s stock price such as:

• Apnimed, Inc.’s current stock price and volume
• Why Apnimed, Inc.’s stock price changed recently
• Upgrades and downgrades for APMD from analysts
• APMD’s stock price momentum as measured by its relative strength

About Apnimed, Inc. (APMD)

Before we jump into Apnimed, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Want to learn more about Apnimed, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Apnimed, Inc..

Apnimed, Inc.’s Stock Price as of Market Close

As of September 18, 2026, 4:00 PM, CST, Apnimed, Inc.’s stock price was $29.000.

Apnimed, Inc. is up 3.17% from its previous closing price of $28.110.

During the last market session, Apnimed, Inc.’s stock traded between $27.990 and $30.220. Currently, there are approximately 4.80 million shares outstanding for Apnimed, Inc..

Apnimed, Inc.’s price-earnings (P/E) ratio is currently at 3.3, which is low compared to the Pharmaceuticals industry median of 17.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Apnimed, Inc. Stock Price History

Apnimed, Inc.’s (APMD) price is currently up 10.48% so far this month.

During the month of September, Apnimed, Inc.’s stock price has reached a high of $30.220 and a low of $25.050.

Over the last year, Apnimed, Inc. has hit prices as high as $35.290 and as low as $16.120.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Apnimed, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 18, 2026, there were analysts who downgraded Apnimed, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Apnimed, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Apnimed, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Apnimed, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Apnimed, Inc. (APMD) by visiting AAII Stock Evaluator.

Relative Price Strength of Apnimed, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 18, 2026, Apnimed, Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Apnimed, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Apnimed, Inc. Stock Price: Bottom Line

As of September 18, 2026, Apnimed, Inc.’s stock price is $29.000, which is up 3.17% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Apnimed, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.